Zobrazeno 1 - 4 of 4 pro vyhledávání: '"Boyd Brooks M"'
1
A phase I, randomized, open-label, single-dose, 3-period crossover study to evaluate the drug-drug interaction between ZX008 (fenfluramine HCl oral solution) and a regimen of stiripentol, clobazam, and valproate in healthy subjects
Autor: Bradley S. Galer, Arnold R. Gammaitoni, Gail Farfel, Steven M. Smith, Boyd Brooks M
Publikováno v: International Journal of Clinical Pharmacology and Therapeutics
Objective Phase I, open-label, randomized, single-dose, 3-period crossover study assessing pharmacokinetics (PK) and safety of ZX008, a liquid oral formulation of fenfluramine (FFA) under development for adjunctive treatment of Dravet syndrome and Le
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecaaad4242ef1a3d3204bf2e1bd2e6dc
https://doi.org/10.5414/cp203276
Zobrazit plný text záznamu
2
The Lack of Effect of Food on the Pharmacokinetics of ZX008 (Fenfluramine Oral Solution): Results of a Single-dose, Two-period Crossover Study
Autor: Steven M. Smith, Boyd Brooks M, Arnold R. Gammaitoni
Publikováno v: Clinical Therapeutics. 40:1338-1346
Purpose Fenfluramine is being developed as a low-dose adjunctive treatment for seizures in patients with Dravet syndrome and other epileptic encephalopathies, including Lennox-Gastaut syndrome. Most patients with Dravet syndrome receive multiple anti
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2254d83527448fb04c9b716e66d8edc4
https://doi.org/10.1016/j.clinthera.2018.05.013
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje